PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |
| PDT Partners, LLC | 64,395 | $1,443,092 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 64,722 | $1,450,420 | 0.17% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,122,698 | $25,159,662 | 0.15% |
| HARBOR CAPITAL ADVISORS, INC. | 29,311 | $656,860 | 0.14% |
| HighVista Strategies LLC | 13,237 | $296,641 | 0.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 17,000 | $380,630 | 0.13% |
| Neo Ivy Capital Management | 11,800 | $264 | 0.12% |
| Blackstone Inc. | 1,095,290 | $24,545,448 | 0.10% |
| DUALITY ADVISERS, LP | 35,973 | $806,155 | 0.10% |
| Virtus ETF Advisers LLC | 7,075 | $158,551 | 0.10% |
External links
This page lists PTC THERAPEUTICS INC's shareholders in Q3 2023. To view PTC THERAPEUTICS INC's shareholder history, click here.